undamentalytics Newsletter
Sign in

Newgenivf Group Ltd revenue

Newgenivf Group Ltd's revenue was $23.7m in fiscal 2025, up 336.3% on the year before. Since fiscal 2021 ($4.1m) it has grown at a compound 54.9% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue465524
Growth on the year before—+44.3%−13.6%+5.8%+336.3%
Gross profit12221
Gross margin24.9%25.9%32.7%33.6%4.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Facilities: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Newgenivf Group Ltd $23.7m 336.3% —
Basel Medical Group Ltd $12.8m 49.9% —
Concord Medical Services Holdings Ltd $64.1m 20.1% -11.2%
Sonida Senior Living, Inc. $526m 49.4% 29.0%
National Healthcare Corp $1.56bn 6.9% 12.8%
Concentra Group Holdings Parent, Inc. $2.29bn 14.0% —

Compare with peers

Head to head: BMGL vs NIVFCCM vs NIVFNIVF vs SNDA

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Newgenivf Group Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Newgenivf Group Ltd.